0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pain Reliever Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6S8529
Home | Market Reports | Health| Pharmacy
Global Pain Reliever Market Insights Forecast to 2028
BUY CHAPTERS

Global Pain Reliever Market Research Report 2025

Code: QYRE-Auto-6S8529
Report
July 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pain Reliever Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pain Reliever Market

Pain Reliever Market

The global market for Pain Reliever was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pain Reliever, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Reliever.
The Pain Reliever market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pain Reliever market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Reliever manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pain Reliever Market Report

Report Metric Details
Report Name Pain Reliever Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Drugstores
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pain Reliever manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pain Reliever in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pain Reliever Market report?

Ans: The main players in the Pain Reliever Market are Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue

What are the Application segmentation covered in the Pain Reliever Market report?

Ans: The Applications covered in the Pain Reliever Market report are Hospitals, Clinics, Drugstores

What are the Type segmentation covered in the Pain Reliever Market report?

Ans: The Types covered in the Pain Reliever Market report are Generic Opioids, Branded Opioids, NSAIDs, Others

Recommended Reports

Pain Drug Markets

Pain Condition Treatments

Drug Delivery & Devices

1 Pain Reliever Market Overview
1.1 Product Definition
1.2 Pain Reliever by Type
1.2.1 Global Pain Reliever Market Value Comparison by Type (2024 VS 2031)
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Pain Reliever by Application
1.3.1 Global Pain Reliever Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Global Pain Reliever Market Size Estimates and Forecasts
1.4.1 Global Pain Reliever Revenue 2020-2031
1.4.2 Global Pain Reliever Sales 2020-2031
1.4.3 Global Pain Reliever Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pain Reliever Market Competition by Manufacturers
2.1 Global Pain Reliever Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pain Reliever Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pain Reliever Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pain Reliever, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pain Reliever, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pain Reliever, Product Type & Application
2.7 Global Key Manufacturers of Pain Reliever, Date of Enter into This Industry
2.8 Global Pain Reliever Market Competitive Situation and Trends
2.8.1 Global Pain Reliever Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pain Reliever Players Market Share by Revenue
2.8.3 Global Pain Reliever Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pain Reliever Market Scenario by Region
3.1 Global Pain Reliever Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pain Reliever Sales by Region: 2020-2031
3.2.1 Global Pain Reliever Sales by Region: 2020-2025
3.2.2 Global Pain Reliever Sales by Region: 2026-2031
3.3 Global Pain Reliever Revenue by Region: 2020-2031
3.3.1 Global Pain Reliever Revenue by Region: 2020-2025
3.3.2 Global Pain Reliever Revenue by Region: 2026-2031
3.4 North America Pain Reliever Market Facts & Figures by Country
3.4.1 North America Pain Reliever Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pain Reliever Sales by Country (2020-2031)
3.4.3 North America Pain Reliever Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pain Reliever Market Facts & Figures by Country
3.5.1 Europe Pain Reliever Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pain Reliever Sales by Country (2020-2031)
3.5.3 Europe Pain Reliever Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pain Reliever Market Facts & Figures by Region
3.6.1 Asia Pacific Pain Reliever Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pain Reliever Sales by Region (2020-2031)
3.6.3 Asia Pacific Pain Reliever Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pain Reliever Market Facts & Figures by Country
3.7.1 Latin America Pain Reliever Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pain Reliever Sales by Country (2020-2031)
3.7.3 Latin America Pain Reliever Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pain Reliever Market Facts & Figures by Country
3.8.1 Middle East and Africa Pain Reliever Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pain Reliever Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pain Reliever Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pain Reliever Sales by Type (2020-2031)
4.1.1 Global Pain Reliever Sales by Type (2020-2025)
4.1.2 Global Pain Reliever Sales by Type (2026-2031)
4.1.3 Global Pain Reliever Sales Market Share by Type (2020-2031)
4.2 Global Pain Reliever Revenue by Type (2020-2031)
4.2.1 Global Pain Reliever Revenue by Type (2020-2025)
4.2.2 Global Pain Reliever Revenue by Type (2026-2031)
4.2.3 Global Pain Reliever Revenue Market Share by Type (2020-2031)
4.3 Global Pain Reliever Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pain Reliever Sales by Application (2020-2031)
5.1.1 Global Pain Reliever Sales by Application (2020-2025)
5.1.2 Global Pain Reliever Sales by Application (2026-2031)
5.1.3 Global Pain Reliever Sales Market Share by Application (2020-2031)
5.2 Global Pain Reliever Revenue by Application (2020-2031)
5.2.1 Global Pain Reliever Revenue by Application (2020-2025)
5.2.2 Global Pain Reliever Revenue by Application (2026-2031)
5.2.3 Global Pain Reliever Revenue Market Share by Application (2020-2031)
5.3 Global Pain Reliever Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Pain Reliever Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Pain Reliever Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Grunenthal
6.3.1 Grunenthal Company Information
6.3.2 Grunenthal Description and Business Overview
6.3.3 Grunenthal Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grunenthal Pain Reliever Product Portfolio
6.3.5 Grunenthal Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Pain Reliever Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Pain Reliever Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly Pain Reliever Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca Pain Reliever Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Endo
6.8.1 Endo Company Information
6.8.2 Endo Description and Business Overview
6.8.3 Endo Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Endo Pain Reliever Product Portfolio
6.8.5 Endo Recent Developments/Updates
6.9 Merck
6.9.1 Merck Company Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck Pain Reliever Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Depomed
6.10.1 Depomed Company Information
6.10.2 Depomed Description and Business Overview
6.10.3 Depomed Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Depomed Pain Reliever Product Portfolio
6.10.5 Depomed Recent Developments/Updates
6.11 Yunnan Baiyao
6.11.1 Yunnan Baiyao Company Information
6.11.2 Yunnan Baiyao Description and Business Overview
6.11.3 Yunnan Baiyao Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Yunnan Baiyao Pain Reliever Product Portfolio
6.11.5 Yunnan Baiyao Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Teva Pain Reliever Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 J&J
6.13.1 J&J Company Information
6.13.2 J&J Description and Business Overview
6.13.3 J&J Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.13.4 J&J Pain Reliever Product Portfolio
6.13.5 J&J Recent Developments/Updates
6.14 Allergan
6.14.1 Allergan Company Information
6.14.2 Allergan Description and Business Overview
6.14.3 Allergan Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Allergan Pain Reliever Product Portfolio
6.14.5 Allergan Recent Developments/Updates
6.15 Purdue
6.15.1 Purdue Company Information
6.15.2 Purdue Description and Business Overview
6.15.3 Purdue Pain Reliever Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Purdue Pain Reliever Product Portfolio
6.15.5 Purdue Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pain Reliever Industry Chain Analysis
7.2 Pain Reliever Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pain Reliever Production Mode & Process Analysis
7.4 Pain Reliever Sales and Marketing
7.4.1 Pain Reliever Sales Channels
7.4.2 Pain Reliever Distributors
7.5 Pain Reliever Customer Analysis
8 Pain Reliever Market Dynamics
8.1 Pain Reliever Industry Trends
8.2 Pain Reliever Market Drivers
8.3 Pain Reliever Market Challenges
8.4 Pain Reliever Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pain Reliever Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pain Reliever Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pain Reliever Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pain Reliever Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pain Reliever Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pain Reliever Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pain Reliever Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pain Reliever Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pain Reliever, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pain Reliever, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pain Reliever, Product Type & Application
 Table 12. Global Key Manufacturers of Pain Reliever, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pain Reliever by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Reliever as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pain Reliever Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pain Reliever Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pain Reliever Sales Market Share by Region (2020-2025)
 Table 19. Global Pain Reliever Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pain Reliever Sales Market Share by Region (2026-2031)
 Table 21. Global Pain Reliever Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pain Reliever Revenue Market Share by Region (2020-2025)
 Table 23. Global Pain Reliever Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pain Reliever Revenue Market Share by Region (2026-2031)
 Table 25. North America Pain Reliever Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pain Reliever Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pain Reliever Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pain Reliever Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pain Reliever Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pain Reliever Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pain Reliever Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pain Reliever Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pain Reliever Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pain Reliever Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pain Reliever Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pain Reliever Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pain Reliever Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pain Reliever Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pain Reliever Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pain Reliever Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pain Reliever Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pain Reliever Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pain Reliever Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pain Reliever Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pain Reliever Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pain Reliever Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pain Reliever Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pain Reliever Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pain Reliever Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pain Reliever Sales (K Units) by Type (2020-2025)
 Table 51. Global Pain Reliever Sales (K Units) by Type (2026-2031)
 Table 52. Global Pain Reliever Sales Market Share by Type (2020-2025)
 Table 53. Global Pain Reliever Sales Market Share by Type (2026-2031)
 Table 54. Global Pain Reliever Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pain Reliever Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pain Reliever Revenue Market Share by Type (2020-2025)
 Table 57. Global Pain Reliever Revenue Market Share by Type (2026-2031)
 Table 58. Global Pain Reliever Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pain Reliever Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pain Reliever Sales (K Units) by Application (2020-2025)
 Table 61. Global Pain Reliever Sales (K Units) by Application (2026-2031)
 Table 62. Global Pain Reliever Sales Market Share by Application (2020-2025)
 Table 63. Global Pain Reliever Sales Market Share by Application (2026-2031)
 Table 64. Global Pain Reliever Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pain Reliever Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pain Reliever Revenue Market Share by Application (2020-2025)
 Table 67. Global Pain Reliever Revenue Market Share by Application (2026-2031)
 Table 68. Global Pain Reliever Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pain Reliever Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Pain Reliever Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Pain Reliever Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Grunenthal Company Information
 Table 81. Grunenthal Description and Business Overview
 Table 82. Grunenthal Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Grunenthal Pain Reliever Product
 Table 84. Grunenthal Recent Developments/Updates
 Table 85. Bayer Company Information
 Table 86. Bayer Description and Business Overview
 Table 87. Bayer Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer Pain Reliever Product
 Table 89. Bayer Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Pain Reliever Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Eli Lilly Company Information
 Table 96. Eli Lilly Description and Business Overview
 Table 97. Eli Lilly Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Eli Lilly Pain Reliever Product
 Table 99. Eli Lilly Recent Developments/Updates
 Table 100. AstraZeneca Company Information
 Table 101. AstraZeneca Description and Business Overview
 Table 102. AstraZeneca Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. AstraZeneca Pain Reliever Product
 Table 104. AstraZeneca Recent Developments/Updates
 Table 105. Endo Company Information
 Table 106. Endo Description and Business Overview
 Table 107. Endo Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Endo Pain Reliever Product
 Table 109. Endo Recent Developments/Updates
 Table 110. Merck Company Information
 Table 111. Merck Description and Business Overview
 Table 112. Merck Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Merck Pain Reliever Product
 Table 114. Merck Recent Developments/Updates
 Table 115. Depomed Company Information
 Table 116. Depomed Description and Business Overview
 Table 117. Depomed Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Depomed Pain Reliever Product
 Table 119. Depomed Recent Developments/Updates
 Table 120. Yunnan Baiyao Company Information
 Table 121. Yunnan Baiyao Description and Business Overview
 Table 122. Yunnan Baiyao Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Yunnan Baiyao Pain Reliever Product
 Table 124. Yunnan Baiyao Recent Developments/Updates
 Table 125. Teva Company Information
 Table 126. Teva Description and Business Overview
 Table 127. Teva Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Teva Pain Reliever Product
 Table 129. Teva Recent Developments/Updates
 Table 130. J&J Company Information
 Table 131. J&J Description and Business Overview
 Table 132. J&J Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. J&J Pain Reliever Product
 Table 134. J&J Recent Developments/Updates
 Table 135. Allergan Company Information
 Table 136. Allergan Description and Business Overview
 Table 137. Allergan Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Allergan Pain Reliever Product
 Table 139. Allergan Recent Developments/Updates
 Table 140. Purdue Company Information
 Table 141. Purdue Description and Business Overview
 Table 142. Purdue Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Purdue Pain Reliever Product
 Table 144. Purdue Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Pain Reliever Distributors List
 Table 148. Pain Reliever Customers List
 Table 149. Pain Reliever Market Trends
 Table 150. Pain Reliever Market Drivers
 Table 151. Pain Reliever Market Challenges
 Table 152. Pain Reliever Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pain Reliever
 Figure 2. Global Pain Reliever Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pain Reliever Market Share by Type: 2024 & 2031
 Figure 4. Generic Opioids Product Picture
 Figure 5. Branded Opioids Product Picture
 Figure 6. NSAIDs Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Pain Reliever Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Pain Reliever Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Drugstores
 Figure 13. Global Pain Reliever Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pain Reliever Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Pain Reliever Sales (2020-2031) & (K Units)
 Figure 16. Global Pain Reliever Average Price (US$/Unit) & (2020-2031)
 Figure 17. Pain Reliever Report Years Considered
 Figure 18. Pain Reliever Sales Share by Manufacturers in 2024
 Figure 19. Global Pain Reliever Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Pain Reliever Players: Market Share by Revenue in Pain Reliever in 2024
 Figure 21. Pain Reliever Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Pain Reliever Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Pain Reliever Sales Market Share by Country (2020-2031)
 Figure 24. North America Pain Reliever Revenue Market Share by Country (2020-2031)
 Figure 25. United States Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Pain Reliever Sales Market Share by Country (2020-2031)
 Figure 28. Europe Pain Reliever Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Pain Reliever Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Pain Reliever Revenue Market Share by Region (2020-2031)
 Figure 36. China Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Pain Reliever Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Pain Reliever Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Pain Reliever Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Pain Reliever Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Pain Reliever Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Pain Reliever by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Pain Reliever by Type (2020-2031)
 Figure 57. Global Pain Reliever Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Pain Reliever by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Pain Reliever by Application (2020-2031)
 Figure 60. Global Pain Reliever Price (US$/Unit) by Application (2020-2031)
 Figure 61. Pain Reliever Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart